We previously identified increases in fucosylated haptoglobin (Fuc-Hp) in the sera of patients with pancreatic cancer and succeeded in establishing a lectin antibody enzyme-linked immunosorbent assay (ELISA) system to measure serum Fuc-Hp levels [11]. This evidence concerns the gene HP and pancreatic neoplasm.